Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Adalimumab for Resistant Crohn Disease

Article PDF
022040024_1.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(4)
Publications
Federal Practitioner
Page Number
24
Legacy Keywords
gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022040024_1.pdf
Article PDF
022040024_1.pdf

Issue
Federal Practitioner - 22(4)
Issue
Federal Practitioner - 22(4)
Page Number
24
Page Number
24
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Adalimumab for Resistant Crohn Disease
Display Headline
Adalimumab for Resistant Crohn Disease
Legacy Keywords
gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha
Legacy Keywords
gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media